The Cardinal Source
CCaaS vendor scorecard.
Acme Manufacturing · 6 vendors evaluated · 14 scoring dimensions
The scoring rubric, Medical Device weights
The rubric below is calibrated for the Medical Device Manufacturing vertical. Weights add to 100%. Each vendor is scored 0–10 on each dimension; weighted score = raw × weight.
| Dimension | Weight | What we measured |
|---|---|---|
| 21 CFR Part 11 compliance | 25% | Audit-trail tamper-evidence, validation pkgs, customer deployments at peer manufacturers |
| MasterControl / quality system integration | 20% | Production integrations, API depth, complaint-record automation |
| HIPAA / BAA / SOC 2 Type 2 | 15% | BAA willingness, SOC 2 audit recency, PHI handling design |
| Total cost of ownership (5yr) | 15% | Licensing + PS + integration + run-rate at year 3 |
| Implementation risk (multi-site) | 10% | Rollback feasibility, PS team experience, peer references at 50+ sites |
| Vendor financial health | 10% | Cash position, growth trajectory, M&A risk |
| AI / voice analytics roadmap | 5% | Production-ready capabilities, not announcements |
Qualified vendor universe
Eleven CCaaS vendors evaluated for initial qualification. Five eliminated at qualification stage: three for inability or unwillingness to sign a 21 CFR Part 11 validation package, one for SOC 2 lapse, one for inadequate MasterControl integration depth. Six entered the scorecard phase.
Weighted scorecard
| Dimension | Weight | NICE CXone | Genesys Cloud | Five9 | Talkdesk | RingCentral CC | Webex CC |
|---|---|---|---|---|---|---|---|
| 21 CFR Part 11 | 25% | 2.25 | 2.00 | 1.75 | 1.25 | 1.00 | 1.50 |
| MasterControl integration | 20% | 1.60 | 1.80 | 1.20 | 1.40 | 0.80 | 1.40 |
| HIPAA / SOC 2 | 15% | 1.35 | 1.35 | 1.20 | 1.20 | 1.05 | 1.20 |
| 5-yr TCO | 15% | 0.90 | 0.75 | 1.20 | 1.05 | 0.90 | 1.05 |
| Implementation risk | 10% | 0.80 | 0.90 | 0.70 | 0.60 | 0.70 | 0.80 |
| Vendor financial health | 10% | 0.80 | 0.80 | 0.70 | 0.50 | 0.60 | 0.95 |
| AI / voice roadmap | 5% | 0.45 | 0.40 | 0.40 | 0.40 | 0.30 | 0.35 |
| Weighted total | 100% | 8.15 | 8.00 | 7.15 | 6.40 | 5.35 | 7.25 |
Cells in cardinal red highlight category winners. Cells in soft red highlight runners-up within 0.25 of the leader.
Top 3 — detail
NICE CXone
Weighted score: 8.15 / 10 · Recommended
Strengths. Best-in-class 21 CFR Part 11 implementation, with three peer medical-device-manufacturer deployments validated by FDA pre-inspection. Production-grade MasterControl integration with sub-3-minute complaint-record automation. Strongest AI/voice analytics roadmap of the six.
Constraints. Highest TCO of the top three over 5 years (~12% above Genesys Cloud). PS team capacity for 78-site multi-region deployment requires booking 6+ months ahead.
Genesys Cloud
Weighted score: 8.00 / 10 · Runner-up
Strengths. Strongest MasterControl integration depth (four production deployments at peer manufacturers including two with 100+ sites). Lowest implementation risk of the six — peer reference checks confirm clean multi-site rollouts. Solid 21 CFR Part 11 story with one validation gap to close.
Constraints. 21 CFR Part 11 implementation is one validation cycle behind NICE CXone — likely closed by go-live but a residual risk.
Cisco Webex Contact Center
Weighted score: 7.25 / 10 · Defensive option
Strengths. Best vendor financial health (top mark on the rubric). Native integration paths to existing UCCE for hybrid retention of clinical-affairs site if needed. Strongest enterprise procurement experience for the IT team.
Constraints. 21 CFR Part 11 implementation lags both NICE and Genesys. Best fit if Acme prefers a Cisco-aligned hybrid retention strategy for the most critical clinical-affairs sites.
Disqualified at scoring stage
- Five9 — Strong TCO and HIPAA, but MasterControl integration is partner-built rather than native, adding 6 weeks of integration risk and dependency on a third-party integrator.
- Talkdesk — 21 CFR Part 11 implementation is behind. Strong elsewhere but the regulatory gap is structural.
- RingCentral CC — Weak MasterControl integration depth (no production peer references) and lower vendor maturity at 360-seat multi-site scale.
Recommendation
Methodology
Scores produced via The Cardinal Method's South Spine stage. Each dimension scored against the rubric by two independent Cardinal Source reviewers; disputes resolved by reference to vendor-supplied artifacts (Part 11 validation packages, BAA contracts, customer references). Peer references contacted: 9 (3 per top-3 vendor). Vendor financial health based on most recent public filings (Genesys, NICE, Cisco) and confidential disclosures (Talkdesk, Five9, RingCentral) as part of RFP response.